Mental health up to 12 months following SARS-CoV-2 infection: A prospective cohort study
Rattachement africain : nl, ca. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
OBJECTIVE: To investigate to what extent individuals report clinically relevant levels of depression, anxiety, post-traumatic stress disorder (PTSD) symptoms and concentration problems up to 12 months following COVID-19 symptom onset, using validated questionnaires. METHODS: RECoVERED, a prospective cohort study in Amsterdam, the Netherlands, enrolled both hospitalized and community-dwelling adult participants diagnosed with SARS-CoV-2. Symptoms of depression and anxiety were assessed with the Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7 1, 3, 6 and 12 months following illness onset. The DSM-V PTSD checklist was administered at month 3 and 9. Concentration problems were assessed using the Checklist Individual Strength concentration subscale at month 1 and 12. Generalized Estimating Equations were used to determine factors related with clinically relevant levels of depression-, anxiety- and PTSD-symptoms and concentration problems over time. RESULTS: In 303 individuals, the prevalence of clinically relevant symptoms of depression, anxiety and concentration problems was 10.6% (95%CI = 7.2-15.4), 7.0% (95%CI = 4.4-11.2) and 33.6% (95%CI = 27.7-40.1), respectively, twelve months after infection. Nine months after illness onset, 4.2% (95%CI = 2.3-7.7) scored within the clinical range of PTSD. Risk factors for an increased likelihood of reporting mental health problems during follow up included initial severe/critical COVID-19, non-Dutch origin, psychological problems prior to COVID-19 and being infected during the first COVID-19 wave. CONCLUSION: Our findings highlight that a minority of patients with COVID-19 face clinically relevant symptoms of depression, anxiety or PTSD up to 12 months after infection. The prevalence of concentration problems was high. This study contributes to the identification of specific groups for which support after initial illness is indicated.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Mental health up to 12 months following SARS-CoV-2 infection: A prospective cohort study
- Date Crossref
- 01/12/2023
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Amsterdam Neuroscience pays non établi dans la noticeStructure de recherche
-
GGD Amsterdam pays non établi dans la noticeÉtablissement de santé
-
Amsterdam University Medical Centers pays non établi dans la noticeÉtablissement de santé
-
University of Amsterdam Department of Infectious Diseases pays non établi dans la noticeUniversité ou école supérieure
-
Public Health Service of Amsterdam pays non établi dans la noticeÉtablissement de santé
-
Institute of Infection and Immunity pays non établi dans la noticeStructure de recherche
-
Amsterdam Public Health pays non établi dans la noticeInstitution
-
Amsterdam Institute for Infection and Immunity pays non établi dans la noticeStructure de recherche
-
Department of Infectious Diseases pays non établi dans la noticeInstitution
Amsterdam Neuroscience, GGD Amsterdam et Amsterdam University Medical Centers, avec 6 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.